UBS reiterates ‘buy’ on Berkeley, lifts price target

by | Feb 18, 2021

UBS lifted its price target on housebuilder Berkeley to 6,037p from 5,882p on Thursday and reiterated the ‘buy’ rating as it highlighted upside of more than 7,000p.
UBS said the size and scale of Berkeley’s land bank is its key differentiator and its analysis suggests that not only can it beat its current six-year target to FY25, but that for the following six years to April 2031, from its already owned and controlled land bank, the group can increase its pre-tax profit target to around £650m to £700m a year.

“Trading at 1.5x 2021 cal P/NTAV Berkeley’s historic premium to the sector is all but eroded,” said UBS. “However while EBIT growth will likely lag housebuilder peers near term, already owning the land to deliver profit before tax up to 15% higher than consensus in FY24, and then to continue at this level until FY31, there is considerable deep value.

“Cap this with a yield of 5% per annum and scope for a series of one-offs to drive meaningful upside, Berkeley is worthwhile considering again.”

UBS said that with nearly three times the length of land bank and three times the build work in progress of others, using a liquidation value to try to capture the value of balance sheet strength, offers upside of more than 7,000p.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x